Clinical Trial Detail

NCT ID NCT04044768
Title Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Adaptimmune
Indications

synovial sarcoma

myxoid liposarcoma

Therapies

ADP-A2M4 cells

Age Groups: adult senior child

No variant requirements are available.